Rapport Therapeutics Ownership | Who Owns Rapport Therapeutics?
Rapport Therapeutics Ownership Summary
Rapport Therapeutics is owned by 35.36% institutional investors, 4.65% insiders, and 59.99% retail investors. Fmr is the largest institutional shareholder, holding 15.26% of RAPP shares. American Funds SMALLCAP World A is the top mutual fund, with 7.60% of its assets in Rapport Therapeutics shares.
RAPP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rapport Therapeutics | 35.36% | 4.65% | 59.99% |
| Sector | Healthcare Stocks | 35.42% | 11.83% | 52.76% |
| Industry | Biotech Stocks | 35.46% | 11.78% | 52.76% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 7.17M | 15.26% | $224.32M |
| Trv gp v | 7.14M | 15.19% | $223.26M |
| Arch venture management | 3.73M | 7.94% | $116.67M |
| Capital investors | 3.10M | 6.59% | $96.94M |
| Cormorant asset management, lp | 2.96M | 6.30% | $92.54M |
| Goldman sachs group | 2.94M | 6.26% | $92.06M |
| Blackrock funding, inc. /de | 2.51M | 5.33% | $78.41M |
| Sofinnova investments | 1.90M | 4.05% | $59.59M |
| Johnson & johnson | 1.78M | 3.80% | $55.84M |
| Polar capital | 1.64M | 3.50% | $51.39M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Trv gp v | 7.14M | 55.68% | $223.26M |
| Trv gp vi | 969.22K | 22.37% | $30.33M |
| Arch venture management | 3.73M | 17.23% | $116.67M |
| Johnson & johnson | 1.78M | 8.56% | $55.84M |
| Cormorant asset management, lp | 2.96M | 4.65% | $92.54M |
| Sofinnova investments | 1.90M | 2.26% | $59.59M |
| Sio capital management | 366.81K | 1.65% | $11.48M |
| Vestal point capital, lp | 1.44M | 1.26% | $44.94M |
| Sphera funds management | 157.53K | 0.99% | $4.68M |
| Artia global partners lp | 138.51K | 0.96% | $4.33M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Polar capital | 1.64M | 0.18% | 637.73K |
| Capital world investors | 536.61K | 0.00% | 536.61K |
| Vestal point capital, lp | 1.44M | 1.26% | 326.23K |
| Vanguard group | 1.82M | 0.00% | 191.22K |
| Vanguard fiduciary trust | 189.25K | 0.00% | 189.25K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | 3.10M | 0.02% | -304.56K |
| Franklin resources | - | - | -250.59K |
| Logos global management lp | - | - | -208.91K |
| Affinity asset advisors | - | - | -199.64K |
| Woodline partners lp | - | - | -185.03K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Capital world investors | 536.61K | 0.00% | 536.61K | $16.79M |
| Vanguard fiduciary trust | 189.25K | 0.00% | 189.25K | $5.92M |
| Candriam s.c.a. | 185.93K | 0.03% | 185.93K | $5.82M |
| Sphera funds management | 157.53K | 0.99% | 157.53K | $4.68M |
| Fort baker capital management lp | 81.64K | 0.38% | 81.64K | $2.42M |
Sold Out
| Holder | Change |
|---|---|
| Farther finance advisors | -1.00 |
| Bare financial services | -16.00 |
| Clearstead advisors | -33.00 |
| Parallel advisors | -50.00 |
| Rise advisors | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 75 | -48.28% | 16,611,270 | -67.48% | 35 | 0.20% | 41 | -54.95% | 18 | -41.94% |
| Dec 31, 2025 | 93 | -29.55% | 28,333,513 | -42.50% | 7 | 3.86% | 62 | -30.34% | 16 | -11.11% |
| Sep 30, 2025 | 129 | 69.74% | 49,256,683 | 36.76% | 13 | 13.46% | 87 | 102.33% | 18 | 12.50% |
| Jun 30, 2025 | 80 | 5.26% | 38,487,484 | 29.20% | 10 | 15.22% | 45 | -15.09% | 18 | 100.00% |
| Mar 31, 2025 | 78 | 16.42% | 38,100,888 | 4.65% | 10 | 0.10% | 52 | 36.84% | 9 | -30.77% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 3.63M | 7.60% | 232.05K |
| Fidelity Growth Compy Commingled Pl S | 3.17M | 6.62% | 313.71K |
| Fidelity Growth Company Fund | 2.23M | 4.66% | 233.40K |
| Polar Capital Biotech S Inc | 1.55M | 3.25% | 53.39K |
| Vanguard Total Stock Mkt Idx Inv | 973.33K | 2.04% | - |
| iShares Russell 2000 ETF | 696.26K | 1.46% | 5.88K |
| Fidelity Growth Company K6 | 687.26K | 1.44% | 56.65K |
| T. Rowe Price Health Sciences | 636.40K | 1.33% | 96.73K |
| Fidelity Series Growth Company | 586.41K | 1.23% | 59.87K |
| Fidelity Select Biotechnology | 471.77K | 0.99% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 11, 2026 | Third Rock Ventures V, L.P. | - | Sell | $5.38M |
| May 08, 2026 | Third Rock Ventures V, L.P. | - | Sell | $202.26K |
| May 07, 2026 | Third Rock Ventures V, L.P. | - | Sell | $10.89M |
| Apr 17, 2026 | Third Rock Ventures V, L.P. | - | Sell | $17.18M |
| Apr 17, 2026 | Yeleswaram Krishnaswamy | Chief Development Officer | Sell | $808.84K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 9 |
| 2026 Q1 | - | 15 |
| 2025 Q4 | - | 23 |
| 2025 Q3 | 4 | 10 |
| 2025 Q2 | - | 3 |
RAPP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools